Communiqués Edwards Lifesciences Corporation

Actions

EW

US28176E1082

Equipement et technologie médicale avancés

Marché Fermé - NYSE Autres places de cotation 22:00:02 29/06/2026			Varia. 5j.	Varia. 1 janv.
91,18 ^USD	+0,44%		+6,17%	+6,96%

29/06	Edwards Lifesciences obtient l'homologation de la FDA pour son système Ecliptis	MT
29/06	Edwards Lifesciences peut maintenir une forte croissance de ses revenus grâce à son leadership technologique, selon RBC	MT

Communiqués

26/06	Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves	BU
12/06	Annual Checkup From The ABA Antitrust In Healthcare Conference	AQ
04/05	Edwards Lifesciences Announces Appointment of CFO	BU
02/05	Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue	BU
28/04	Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference	BU
23/04	Edwards Lifesciences Reports First Quarter Results	BU
16/04	Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026	BU
30/03	Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits	BU
26/02	Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose	BU
19/02	Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences	BU
16/02	Achy Breaky Heart: The FTC Blocks Edwards-JenaValve Aortic Device Deal	AQ
13/02	Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day	BU
10/02	Edwards Lifesciences Reports Fourth Quarter Results	BU
09/02	FTC Win Clarifies Antitrust Enforcement In Development Pipeline Deals	AQ
05/02	Seal The Valve, But Not The Deal: Court Blocks Edwards Lifesciences' Pre Commercial Merger	AQ
03/02	Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026	BU
02/02	Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference	BU
12/01	Edwards Comments on JenaValve Acquisition	AQ
10/01	Edwards Comments on JenaValve Acquisition	BU
26/12	Federal Circuit Affirms Implicit Redefinition Of Claim Terms	AQ
24/12	HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR
23/12	FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy	BU
18/12	Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference	BU
11/12	Is Writing Your Own Dictionary Dangerous? Yes.	AQ
05/12	Edwards Lifesciences : EW 2025 IC FINAL	PU